Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

Proposals for uniform collection of biospecimens from neoadjuvant breast cancer clinical trials: timing and specimen types.

Loi S, Symmans WF, Bartlett JM, Fumagalli D, Van't Veer L, Forbes JF, Bedard P, Denkert C, Zujewski J, Viale G, Pusztai L, Esserman LJ, Leyland-Jones BR.

Lancet Oncol. 2011 Nov;12(12):1162-8. doi: 10.1016/S1470-2045(11)70117-6.

PMID:
21684810
[PubMed - indexed for MEDLINE]
2.

Technology insight: Application of molecular techniques to formalin-fixed paraffin-embedded tissues from breast cancer.

Paik S, Kim CY, Song YK, Kim WS.

Nat Clin Pract Oncol. 2005 May;2(5):246-54. Review.

PMID:
16264960
[PubMed - indexed for MEDLINE]
3.

[Histological and cytopathological cancer specimens: good practice in operating room].

Benoit L, Favoulet P, Collin F, Arnould L, Fraisse J, Cuisenier J.

Ann Chir. 2003 Nov;128(9):637-41. Review. French.

PMID:
14659622
[PubMed - indexed for MEDLINE]
4.

[Sentinel lymph node and neoadjuvant therapy in breast cancer: searching for the best scenario].

Solá M, Fraile M.

Rev Esp Med Nucl. 2010 Nov-Dec;29(6):316-8. doi: 10.1016/j.remn.2010.10.001. Review. Spanish. No abstract available.

PMID:
21055516
[PubMed - indexed for MEDLINE]
5.

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

PMID:
16959170
[PubMed - indexed for MEDLINE]
Free Article
6.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
[PubMed - indexed for MEDLINE]
7.

Neoadjuvant chemotherapy for early breast cancer.

Mieog JS, van de Velde CJ.

Expert Opin Pharmacother. 2009 Jun;10(9):1423-34. doi: 10.1517/14656560903002105. Review.

PMID:
19505212
[PubMed - indexed for MEDLINE]
8.

Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference.

Buchholz TA, Lehman CD, Harris JR, Pockaj BA, Khouri N, Hylton NF, Miller MJ, Whelan T, Pierce LJ, Esserman LJ, Newman LA, Smith BL, Bear HD, Mamounas EP.

J Clin Oncol. 2008 Feb 10;26(5):791-7. doi: 10.1200/JCO.2007.15.0326. Review.

PMID:
18258988
[PubMed - indexed for MEDLINE]
9.

[Sentinel node biopsy in breast cancer: techniques and indications].

Haid A, Knauer M, Köberle-Wührer R, Wenzl E.

Wien Klin Wochenschr. 2005 Feb;117(4):121-8. Review. German.

PMID:
15847190
[PubMed - indexed for MEDLINE]
11.

Neoadjuvant chemotherapy in breast cancer.

Charfare H, Limongelli S, Purushotham AD.

Br J Surg. 2005 Jan;92(1):14-23. Review.

PMID:
15635596
[PubMed - indexed for MEDLINE]
12.

Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry.

Yaziji H, Taylor CR, Goldstein NS, Dabbs DJ, Hammond EH, Hewlett B, Floyd AD, Barry TS, Martin AW, Badve S, Baehner F, Cartun RW, Eisen RN, Swanson PE, Hewitt SM, Vyberg M, Hicks DG; Members of the Standardization Ad-Hoc Consensus Committee.

Appl Immunohistochem Mol Morphol. 2008 Dec;16(6):513-20. doi: 10.1097/PAI.0b013e31818a9d3a.

PMID:
18931614
[PubMed - indexed for MEDLINE]
13.

[Breast cancer: figures and facts].

Kubista E.

Wien Med Wochenschr. 2001;151(21-23):548-51. Review. German.

PMID:
11762252
[PubMed - indexed for MEDLINE]
14.

Commercialized multigene predictors of clinical outcome for breast cancer.

Ross JS, Hatzis C, Symmans WF, Pusztai L, Hortobágyi GN.

Oncologist. 2008 May;13(5):477-93. doi: 10.1634/theoncologist.2007-0248. Review. Erratum in: Oncologist. 2008 Aug;13(8). doi: 10.1634/theoncologist.2007-0248.

PMID:
18515733
[PubMed - indexed for MEDLINE]
Free Article
15.

Determination of estrogen receptors in paraffin-embedded tissue. Techniques and the value in breast cancer treatment.

Andersen J.

Acta Oncol. 1992;31(6):611-27. Review.

PMID:
1281648
[PubMed - indexed for MEDLINE]
16.

Neoadjuvant therapy for breast cancer.

Liu SV, Melstrom L, Yao K, Russell CA, Sener SF.

J Surg Oncol. 2010 Mar 15;101(4):283-91. doi: 10.1002/jso.21446. Review.

PMID:
20187061
[PubMed - indexed for MEDLINE]
17.

Neoadjuvant taxanes in the treatment of non-metastatic breast cancer: a systematic review.

Trudeau M, Sinclair SE, Clemons M; Breast Cancer Disease Site Group.

Cancer Treat Rev. 2005 Jun;31(4):283-302. Review.

PMID:
15916855
[PubMed - indexed for MEDLINE]
18.
19.

The role of cytology specimens in molecular testing of solid tumors: techniques, limitations, and opportunities.

Aisner DL, Sams SB.

Diagn Cytopathol. 2012 Jun;40(6):511-24. doi: 10.1002/dc.22820. Review.

PMID:
22619126
[PubMed - indexed for MEDLINE]
20.

CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap.

Nahid P, Saukkonen J, Mac Kenzie WR, Johnson JL, Phillips PP, Andersen J, Bliven-Sizemore E, Belisle JT, Boom WH, Luetkemeyer A, Campbell TB, Eisenach KD, Hafner R, Lennox JL, Makhene M, Swindells S, Villarino ME, Weiner M, Benson C, Burman W; National Institutes of Health; Centers for Disease Control and Prevention.

Am J Respir Crit Care Med. 2011 Oct 15;184(8):972-9. doi: 10.1164/rccm.201105-0827WS.

PMID:
21737585
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk